SB 155 Modifies provisions relating to prescription drug co-payments
Sponsor: Schaaf
LR Number: 0350S.01I Fiscal Notes
Committee: Insurance and Banking
Last Action: 2/7/2017 - Hearing Cancelled S Insurance and Banking Committee Journal Page:
Title: Calendar Position:
Effective Date: August 28, 2017

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2017 Senate Bills

Current Bill Summary

SB 155 – This act requires an enrollee in an HMO or health insurance plan to pay only the usual and customary retail price of a prescription drug if the co-payment applied by an HMO or health insurer exceeds the usual and customary retail price, and provides that there shall be no further charge to the enrollee or plan sponsor for such prescription.

This act is identical to SB 843 (2016) and SB 674 (2012).